Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410295 (US10370388, Compound Angiotensin) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 0.898 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318822 (US10370388, Compound Losartin | US9624243, Losarti...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid PDB UniChem | US Patent | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410295 (US10370388, Compound Angiotensin) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410289 (US10370388, Compound 138) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.52 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318822 (US10370388, Compound Losartin | US9624243, Losarti...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid PDB UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318782 ((2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-fluorophen...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410270 (US10370388, Compound 114) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 17.1 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318790 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(5-phenyl-1H-1,2,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318810 ((2S,4S)-1-(2,2-diphenylacetyl)-4-((2-fluorophenoxy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 20.5 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410246 (US10370388, Compound 87) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 43.6 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318761 ( (2S,4S)-4-(3-benzylpiperidin-1-yl)-1-(2,2-dipheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 43.9 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318773 ( (2S,4S)-4-(2-benzylpiperidin-1-yl)-1-(2,2-dipheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 49.1 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410222 (US10370388, Compound 51) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 50.3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410208 (US10370388, Compound 15) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 54.5 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318806 ((2S,4S)-4-((benzylthio)methyl)-1-(2,2-diphenylacet...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 57.7 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318758 ((2S,4S)-1-(2,2-diphenylacetyl)-4-((R)-3-phenylpipe...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 58.8 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318750 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-phenylp...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62.1 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410271 (US10370388, Compound 52) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 63.2 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318781 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(4-phenylb...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 64.2 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318760 (US10370388, Compound 50 | US9624243, 51) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 67.3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410240 (US10370388, Compound 84) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 75.8 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410229 (US10370388, Compound 61-A | US10370388, Compound 6...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 83.3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318753 ((2S,4S)-4-((S)-3-benzylmorpholino)-1-(2,2-diphenyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 86.9 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318815 ((2S,4S)-1-(2,2-diphenylacetyl)-44(3-(4-fluoropheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 89 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410219 (US10370388, Compound 48) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 89.4 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318744 ((2S,4S)-4-cinnamyloxy-1-(2,2-diphenylacetyl)pyrrol...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318746 ( (2S,4R)-1-(2,2-diphenylacetyl)-4-(3-phenylpropoxy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 98.6 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410243 (US10370388, Compound 85) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 103 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410229 (US10370388, Compound 61-A | US10370388, Compound 6...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 107 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318742 ((2S,4S)-4-(benzyloxy)-1-(2,2-diphenylacetyl)pyrrol...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 114 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318784 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-pyridin...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 126 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318783 ((2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-methoxy-3-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 134 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318807 ((2S,4S)-1-(2,2-diphenylacetyl)-4-((phenylthio)meth...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 143 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410224 (US10370388, Compound 54) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 155 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318816 ((2S,4S)-1-(2,2diphenylacetyl)-4˜03-(4-fluorop...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 173 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318745 (Compound 9 (2S,4R)-1-(2,2-diphenylacetyl)-4-(3-phe...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 181 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318743 ((2S,4R)-4-(benzyloxy)-1-(2,2-diphenylacetyl)pyrrol...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 193 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318814 ((2S,4S)-1-(2,2-diphenylacetyl)-N-(methylsulfonyl)-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318788 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(N-3-phenylpropyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318759 ((2S,4S)—N—(N,N-dimethylsulfamoyl)-1-(2,2...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 255 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410214 (US10370388, Compound 23) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318803 ((2S,4S)-4-((benzylsulfonyl)methyl)-1-(diphenylacet...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 314 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410226 (US10370388, Compound 56) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 316 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318801 ( (2S,4S)-4-(6-benzyl-7-oxa-2,6-diazaspiro[4,5]deca...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 321 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318808 ((2S,4S)-1-(2,2-diphenylacetyl)-4-((3-phenylpropyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 363 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318764 (1-((2R,3S)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-a...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 372 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318751 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(phenyleth...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 384 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318763 ((2S,4R)-4-(2-(benzyloxy)ethyl)-1-(2,2-diphenylacet...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 386 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318791 ((2S,4S)-4-(5-benzyl-1H-1,2,3-triazol-1-yl)-1-(2,2-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318795 ( (2S,4S)-1-(2,2-diphenylacetyl)-4-(4-phenylbutyl)-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 426 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318787 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(N-methyl-3-pheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 458 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318796 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(3-phenylthiophen...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 461 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318769 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl((2-phenyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 483 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318792 ((2S,4S)-4-((S)-3-benzyl-5-oxomorpholino)-1-(2,2-di...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 499 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318785 ((2S,4R)-4-(cinnamyloxy)-1-(2,2-diphenylacetyl)pyrr...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 512 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318789 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(N-(3-phenylpropy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 536 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410216 (US10370388, Compound 35) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 540 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318768 ((2S,4S)-1-(2-cyclohexyl-2-phenylacetyl)-4-(methyl(...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 540 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318798 ((1-((2R,3R)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 650 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318802 ( (2S,4S)1-(2,2-diphenylacetyl)-4-(methyl(3-phenylp...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 650 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318811 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(phenethylthio)py...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 652 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318819 ( (S)-1-(2,2-diphenylacetyl)-4-(4-phenylbut-1-yn-1-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 674 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410245 (US10370388, Compound 86) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 817 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318813 ((2S,4S)-1-(2,2-diphenylacetyl)-4((3-(4-fluoropheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 954 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318820 ( (2S,3S)-1-(2,2-diphenylacetyl)-3-(3-phenylpropoxy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 993 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410276 (US10370388, Compound 120) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318809 ( (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-phenylpropyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.24E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318793 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(3-(4-fluoropheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.32E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318774 ( (2R,4R)-4-(2-benzylpiperidin-1-yl)-1-(2,2-dipheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.34E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318771 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(3-oxo-4-phenyl-2...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.61E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410217 (US10370388, Compound 36) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.66E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318812 ((2S,4S)-1-(2,2-diphenylacetyl)-4((3-(4-fluoropheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.74E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318797 (1-((2R,3S)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-a...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318754 (Compound 96 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-ph...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318756 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(phenethylamino)-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318794 ((2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-methoxy-3-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.49E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318818 ( (S)-1-(2,2-diphenylacetyl)-4-(3-phenylthiophen-2-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.53E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318804 ((2S,4S)-4-((phenylsulfonyl)methyl)-1-(diphenylacet...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410227 (US10370388, Compound 58) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410233 (US10370388, Compound 64) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.36E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM410239 (US10370388, Compound 76) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318772 ((3R,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-phenylp...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318775 ( (2S,4S)-1-(2,2-diphenylacetyl)-4-(1-oxo-3-phenyl-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.83E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318749 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(((1R,2S)-2-pheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.97E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Angiotensin II receptor (Homo sapiens (Human)) | BDBM318748 ((2S,4S)-1-(2,2-diphenylacetyl)-4-(((1R,2R)-2-pheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG US Patent | Assay Description 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ... | US Patent US10370388 (2019) BindingDB Entry DOI: 10.7270/Q2K35X1F | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
